Carcinotech Ltd Revenue and Competitors
Employee Data
- Carcinotech Ltd has 16 Employees.
- Carcinotech Ltd grew their employee count by 45% last year.
Carcinotech Ltd's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Head Operations | Reveal Email/Phone |
3 | Head Business Development | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Chairman | Reveal Email/Phone |
6 | Scientific Project Lead | Reveal Email/Phone |
7 | Marketing Associate | Reveal Email/Phone |
8 | Admin and Operations Assistant | Reveal Email/Phone |
Carcinotech Ltd Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 16 | 45% | N/A | N/A |
What Is Carcinotech Ltd?
Carcinotech is a MedTech company manufacturing 3D printed tumours using patient-derived cancer stem cells, primary cells and established cell lines. Our advanced models provide a platform for rapid, ethical and accurate drug discovery, screening and pre-clinical testing. We work with global partners, leading pharma companies, surgeons, pathologists, clinicians and industry-leaders to accelerate drug discovery and bring more effective cancer treatments to market. Our AI-driven automated manufacturing allows for accelerated production, with models offering high-throughput capabilities. Carcinotech also offers bespoke manufacturing, with clients able to customise the printed tumours according to their testing needs. We are a team of like-minded, highly-experienced and determined individuals, all sharing a vision for success. Learn more about our models, get in touch.
keywords:N/AN/A
Total Funding
16
Number of Employees
N/A
Revenue (est)
45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 16 | 167% | N/A |
#2 | $1.4M | 16 | -27% | N/A |
#3 | $1M | 16 | 14% | N/A |
#4 | $3.1M | 16 | N/A | N/A |
#5 | $1.2M | 16 | N/A | N/A |